Cargando…

1044 Efficacy of Ceftolozane/Tazobactam vs Levofloxacin in the Treatment of Complicated Urinary Tract Infections (cUTI) caused by Levofloxacin-resistant Pathogens: Results from the ASPECT-cUTI Trial

Detalles Bibliográficos
Autores principales: Sakoulas, George, Umeh, Obiamiwe, Huntington, Jennifer, Cloutier, Daniel, Steenbergen, Judith, Yuan, Guojun, Yoon, Minjung, Goldstein, Ellie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781810/
http://dx.doi.org/10.1093/ofid/ofu052.752
_version_ 1783295045342855168
author Sakoulas, George
Umeh, Obiamiwe
Huntington, Jennifer
Cloutier, Daniel
Steenbergen, Judith
Yuan, Guojun
Yoon, Minjung
Goldstein, Ellie
author_facet Sakoulas, George
Umeh, Obiamiwe
Huntington, Jennifer
Cloutier, Daniel
Steenbergen, Judith
Yuan, Guojun
Yoon, Minjung
Goldstein, Ellie
author_sort Sakoulas, George
collection PubMed
description
format Online
Article
Text
id pubmed-5781810
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-57818102018-03-01 1044 Efficacy of Ceftolozane/Tazobactam vs Levofloxacin in the Treatment of Complicated Urinary Tract Infections (cUTI) caused by Levofloxacin-resistant Pathogens: Results from the ASPECT-cUTI Trial Sakoulas, George Umeh, Obiamiwe Huntington, Jennifer Cloutier, Daniel Steenbergen, Judith Yuan, Guojun Yoon, Minjung Goldstein, Ellie Open Forum Infect Dis IDWeek 2014 Abstracts Oxford University Press 2014-12 2014-12 /pmc/articles/PMC5781810/ http://dx.doi.org/10.1093/ofid/ofu052.752 Text en © The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America
spellingShingle IDWeek 2014 Abstracts
Sakoulas, George
Umeh, Obiamiwe
Huntington, Jennifer
Cloutier, Daniel
Steenbergen, Judith
Yuan, Guojun
Yoon, Minjung
Goldstein, Ellie
1044 Efficacy of Ceftolozane/Tazobactam vs Levofloxacin in the Treatment of Complicated Urinary Tract Infections (cUTI) caused by Levofloxacin-resistant Pathogens: Results from the ASPECT-cUTI Trial
title 1044 Efficacy of Ceftolozane/Tazobactam vs Levofloxacin in the Treatment of Complicated Urinary Tract Infections (cUTI) caused by Levofloxacin-resistant Pathogens: Results from the ASPECT-cUTI Trial
title_full 1044 Efficacy of Ceftolozane/Tazobactam vs Levofloxacin in the Treatment of Complicated Urinary Tract Infections (cUTI) caused by Levofloxacin-resistant Pathogens: Results from the ASPECT-cUTI Trial
title_fullStr 1044 Efficacy of Ceftolozane/Tazobactam vs Levofloxacin in the Treatment of Complicated Urinary Tract Infections (cUTI) caused by Levofloxacin-resistant Pathogens: Results from the ASPECT-cUTI Trial
title_full_unstemmed 1044 Efficacy of Ceftolozane/Tazobactam vs Levofloxacin in the Treatment of Complicated Urinary Tract Infections (cUTI) caused by Levofloxacin-resistant Pathogens: Results from the ASPECT-cUTI Trial
title_short 1044 Efficacy of Ceftolozane/Tazobactam vs Levofloxacin in the Treatment of Complicated Urinary Tract Infections (cUTI) caused by Levofloxacin-resistant Pathogens: Results from the ASPECT-cUTI Trial
title_sort 1044 efficacy of ceftolozane/tazobactam vs levofloxacin in the treatment of complicated urinary tract infections (cuti) caused by levofloxacin-resistant pathogens: results from the aspect-cuti trial
topic IDWeek 2014 Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781810/
http://dx.doi.org/10.1093/ofid/ofu052.752
work_keys_str_mv AT sakoulasgeorge 1044efficacyofceftolozanetazobactamvslevofloxacininthetreatmentofcomplicatedurinarytractinfectionscuticausedbylevofloxacinresistantpathogensresultsfromtheaspectcutitrial
AT umehobiamiwe 1044efficacyofceftolozanetazobactamvslevofloxacininthetreatmentofcomplicatedurinarytractinfectionscuticausedbylevofloxacinresistantpathogensresultsfromtheaspectcutitrial
AT huntingtonjennifer 1044efficacyofceftolozanetazobactamvslevofloxacininthetreatmentofcomplicatedurinarytractinfectionscuticausedbylevofloxacinresistantpathogensresultsfromtheaspectcutitrial
AT cloutierdaniel 1044efficacyofceftolozanetazobactamvslevofloxacininthetreatmentofcomplicatedurinarytractinfectionscuticausedbylevofloxacinresistantpathogensresultsfromtheaspectcutitrial
AT steenbergenjudith 1044efficacyofceftolozanetazobactamvslevofloxacininthetreatmentofcomplicatedurinarytractinfectionscuticausedbylevofloxacinresistantpathogensresultsfromtheaspectcutitrial
AT yuanguojun 1044efficacyofceftolozanetazobactamvslevofloxacininthetreatmentofcomplicatedurinarytractinfectionscuticausedbylevofloxacinresistantpathogensresultsfromtheaspectcutitrial
AT yoonminjung 1044efficacyofceftolozanetazobactamvslevofloxacininthetreatmentofcomplicatedurinarytractinfectionscuticausedbylevofloxacinresistantpathogensresultsfromtheaspectcutitrial
AT goldsteinellie 1044efficacyofceftolozanetazobactamvslevofloxacininthetreatmentofcomplicatedurinarytractinfectionscuticausedbylevofloxacinresistantpathogensresultsfromtheaspectcutitrial